Found 9 matching trials
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib PHASE2 This study is a prospective, open label, randomized controlled clinical tri...
Show More Location
Fudan University Shanghai Cencer Center,
Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib PHASE2 This study is a single arm, exploratory clinical study aimed at evaluating ...
Show More Status
Enrolling By Invitation
Location
Henan Tumor Hospital
Learn More & Join Trial
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC PHASE2 The aim of this study is to investigate the safety and efficacy of the prop...
Show More Location
Taixing People's Hospital
Learn More & Join Trial
Myeloprotection With Trilaciclib in Pan-cancer Population PHASE2 The goal of this open-label randomized controlled study is to assess the my...
Show More Location
Medical Oncology,Sun Yat-sen University Cancer Center
Learn More & Join Trial
Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma N/A Clinical data of patients with synchronous radiotherapy for esophageal canc...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer) PHASE2 Triple negative breast cancer (TNBC) has attracted much attention due to it...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin PHASE2 This prospective, randomized, controlled phase II study aims to evaluate th...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer PHASE2 This study is a double-arm, randomized, controlled, single-center, phase II...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial